Alessandra Recchia
Centre for Regenerative Medicine,
Department of Life Sciences,
Centre for Regenerative Medicine, Department of Life Sciences
University of Modena and Reggio Emilia
Alessandra Recchia has not added Biography.
If you are Alessandra Recchia and would like to personalize this page please email our Author Liaison for assistance.
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2006 | Pubmed ID: 16432223
Site-specific integration into the human genome: ready for clinical application?
Rejuvenation research , 2006 | Pubmed ID: 17105384
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.
Nature medicine Dec, 2006 | Pubmed ID: 17115047
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination.
The Journal of cell biology Jun, 2007 | Pubmed ID: 17576799
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.
The Journal of clinical investigation Aug, 2007 | Pubmed ID: 17671653
Tracking gene-modified T cells in vivo.
Methods in molecular biology (Clifton, N.J.) , 2009 | Pubmed ID: 19110640
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.
PloS one , 2009 | Pubmed ID: 19238208
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.
Molecular therapy : the journal of the American Society of Gene Therapy May, 2009 | Pubmed ID: 19293778
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion.
PloS one , 2010 | Pubmed ID: 21203516
Site-specific integration by the adeno-associated virus rep protein.
Current gene therapy Oct, 2011 | Pubmed ID: 21827397
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.
Nucleic acids research Mar, 2013 | Pubmed ID: 23275534
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination.
Molecular therapy : the journal of the American Society of Gene Therapy Sep, 2013 | Pubmed ID: 23760447
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.
Stem cell reports Jan, 2014 | Pubmed ID: 24511464
Long-term skin regeneration from a gene-targeted human epidermal stem cell clone.
Molecular therapy : the journal of the American Society of Gene Therapy Nov, 2014 | Pubmed ID: 25365983
Genomic analysis of Sleeping Beauty transposon integration in human somatic cells.
PloS one , 2014 | Pubmed ID: 25390293
A single epidermal stem cell strategy for safe ex vivo gene therapy.
EMBO molecular medicine Apr, 2015 | Pubmed ID: 25724200
Nuclear architecture dictates HIV-1 integration site selection.
Nature May, 2015 | Pubmed ID: 25731161
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy.
Molecular therapy. Methods & clinical development , 2015 | Pubmed ID: 26509184
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase.
Molecular therapy. Methods & clinical development , 2016 | Pubmed ID: 27574698
In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.
Molecular therapy. Nucleic acids Nov, 2016 | Pubmed ID: 27874856
Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
The Journal of investigative dermatology Apr, 2017 | Pubmed ID: 28027893
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。